Eli Lilly to acquire Adverum Biotechnologies and expand gene therapy portfolio with Ixo-vec
The acquisition will add Adverum’s intravitreal gene therapy programme for wet age-related macular degeneration to Lilly’s…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.